Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

Bristol-Myers Squibb has a market cap or net worth of CHF107.90B. The enterprise value is CHF151.99K.

Bristol-Myers Squibb has 2,042,714,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bristol-Myers Squibb’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 15.03%.

The current PE Ratio of Bristol-Myers Squibb is 14.4. Bristol-Myers Squibb’s PEG ratio is -0.09.

In the last 12 months, Bristol-Myers Squibb had revenue of 48.20B and earned 7.05B in profits. Earnings per share was 3.46.

In the last 12 months, operating cash flow was 12.78B and capital expenditures -1.34B, giving a free cash flow of 11.44B billion.

Bristol-Myers Squibb pays an annual dividend of CHF0.512, resulting in a dividend yield of 4.18%

Bristol-Myers Squibb upcoming earnings date is Oct 29, 2026, Before Open (Confirmed).

Bristol-Myers Squibb as a current ratio of 1.26, with Debt / Equity ratio of 193.20%

In the past 12 months, Bristol-Myers Squibb has paid 2.27B in taxes.

Bristol-Myers Squibb EV to EBITDA ratio is 9.65, with an EV/FCF ratio of 11.45.

Bristol-Myers Squibb has CHF11.07B in cash and marketable securities with CHF43.12B in debt, giving a net cash position of -CHF32.05B billion.

Gross margin is 70.16%, with operating margin of 28.48%, and net profit margin of 14.64%.

The average price target for Bristol-Myers Squibb is CHF53.62, which is 11.43% higher than the current price. The consensus rating is Moderate Buy